This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Informa Connect’s Life Sciences Pricing & Contracting USA May 21-23, 2024 | New Orleans Drug Channels readers save 10% with code 24DRCH10* Whether your daily focus is on Medicaid, Government Pricing, 340B, DrugPrice Transparency, Commercial Contracting or Chargebacks , we have you covered!
Informa Connect-CBI’s 6th Edition DrugPricing Transparency Congress. November 16-17, 2020 | Virtual Event www.informaconnect.com/drug-pricing-transparency. Drug Channels Readers: View the complete agenda and register today. Offer not valid on workshop only or academic/non-profit registrations.
As you work to navigate the evolving healthcare landscape, this annual event brings together 60+ expert speakers from 70+ companies to lead the critical discussions that will drive comprehensive market strategy, uniting Medicaid, Policy, Pricing, Contracting & Reporting thought leaders.
On September 18-20, Informa Connect will hold its annual #MDRPSummit in Chicago (and via livestream) to discuss the complex, ever-evolving laws and regulations in the government pricing and price reporting space. A complete agenda is available here. Hyman, Phelps & McNamara, P.C.’s
Other expert and thought leaders from within the industry are slated to present deep dive sessions, workshops and panels that will answer your most pressing questions: What are the latest legislative updates and proposed federal bills impacting PBM operations? What are the most effective strategies for spread pricing and reimbursement models?
MDRP Agenda Highlights Include: Congressional Insights from the Senior Health Advisor to the Senate Committee on Finance Examination of the 30 Year History of 340B, with current insights into the latest litigation Coverage on FSS Refresh and Life Cycle, PLUS sessions on other federal, state and local contracting agreements that you may be missing Insights (..)
You would be remiss not to join seasoned leaders, your peers and leading solution providers as they navigate marketplace trends and dive into the impact coupons, accumulators, maximizers, benefit design, innovation and drugpricing legislation have on patient affordability and out-of-pocket costs and provide critical insights on industry standards, (..)
You’ll benefit from three days of learning, education and networking, and will return to the office having mastered regulatory guidelines to deliver compliant government pricing and reporting programs. OIG Address - The Office of the Inspector General reviews recent OIG evaluations involving prescription drugpricing, payment and coverage.
With drugpricing legislation growing more complex, ongoing enforcement actions, accumulator and maximizer programs affecting patients and the rise of PBM cost-shifting strategies, there has never been a more important time for industry to unite. Copay, Reimbursement and Access Congress is back and we have a lot to talk about!
Drugprices crash post-patent loss, due to this competition, which is good for patients but leaves drug makers struggling with thin profit margins. The 17-page report acknowledges that ten of the top 20 generic companies in the US are Indian, and Indian companies command over 40 per cent Gx prescription shares.
Event Sharing & Collaboration: Looking for Health AI conferences or workshops? Ask questions, share your expertise, and participate in stimulating discussions on the latest trends, challenges, and opportunities in the field. Lead the Conversation: Have a burning question about the ethical implications of AI?
Drug Channels readers save 10% off the current registration rate with promo code 21PSSDC10.* Offer not valid on workshop only or academic/non-profit registrations. Drug Channels, or any of its employees. Register today. Register today.
Theyre blamed for everything from insurance issues and drug shortages to skyrocketing drugprices, while the credit for the lives they save often goes unnoticed. This isnt just a workshop; its a career reset. What happened to the job that many once loved? Pharmacists have become the healthcare systems punching bag.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content